Rapt Therapeutics Inc. sell Lokrim
Start price
23.12.24
/
20%
€1.56
Target price
23.12.25
-
Performance (%)
-42.63%
Price
16.06.25
€0.90
Summary
This prediction is currently active. Massive losses of -42.63% have been the result for the SELL prediction by Lokrim. This prediction currently runs until 23.12.25. The prediction end date can be changed by Lokrim at any time. Lokrim has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rapt Therapeutics Inc. | - | - |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
According to Lokrim what are the pros and cons of Rapt Therapeutics Inc. for the foreseeable future?
Pros
Cons
Business model of the past or high risk
Comments by Lokrim for this prediction
In the thread Rapt Therapeutics Inc. diskutieren
Sell Rapt Therapeutics Inc.